4//SEC Filing
Geffner Michael 4
Accession 0001764013-25-000114
CIK 0001764013other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 5:10 PM ET
Size
5.3 KB
Accession
0001764013-25-000114
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Geffner Michael
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-07-23$18.15/sh−2,385$43,288→ 221,825 total
Footnotes (1)
- [F1]On January 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 3 filed on January 16, 2024, of which 6,250 of these RSUs vested on July 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0002007249
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 5:10 PM ET
- Size
- 5.3 KB